Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)

Name: Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)
License: Public Domain

Celgene

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

non

lymphoma, non-hodgkin

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 353262
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.